Companies to submit vaccine for emergency authorisation in the US ‘within days’
Companies to submit vaccine for emergency authorisation in the US ‘within days’
New analysis of prespecified subgroup comes from phase III THALES trial
Collaboration will focus on developing exosome therapeutics for rare diseases
Designation is based on results from phase IIb/III HPTN 083 trial
Initial purchase includes 225 million doses of mRNA-based vaccine
MPs launch inquiry with view of securing extra support for sector
Companies will develop oral small molecule treatments
Drug combinations tested were found to be well tolerated
Initial interim data suggests vaccine is 94.5% effective
It is hoped that the move will help to tackle the persistent symptoms – such as fatigue and brain fog – suffered by people who have developed the condition
The funds will help expand the scale of SARS-CoV-2 virus sequencing in the hope of revealing new opportunities for intervention
Janssen will enrol participants in countries with high incidence of COVID-19, including the UK
The recommendations include new treatments for cancer and intraocular pressure and prevention of uncomplicated flu.
Medicines Discovery Catapult (MDC) will offer industry skills and discovery platforms
Research centres will accelerate development of late-stage research within NHS